What is the Impavido treatment?
•
3 min read
With an estimated 350 million people worldwide at risk, leishmaniasis is a serious parasitic disease that can manifest in various forms. The development of effective oral treatments, such as the Impavido treatment (miltefosine), has significantly improved patient care for this often-neglected tropical disease.
